PMA device
Macroplastique Implants
Uroplasty, LLC · Agent, Bulking, Injectable For Gastro-Urology Use (LNM, Class III) · First FDA decision Oct 30, 2006, newest May 9, 2023Overactive bladder and urinary incontinence
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
PMA pathway
Device trials
18
Naming "Macroplastique"
MAUDE reports
34
Brand "Macroplastique", since 2015
PubMed studies
122
Mentioning "Macroplastique"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Macroplastique Implants
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 8 decisions filed under this name.
- Macroplastique ImplantsPMA supplement
P040050-S013 · Decided May 9, 2023 · 361 days after receipt · Normal 180 Day Track No User Fee
Device type: AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE (LNM) · GI, Urology & Nephrology
- Macroplastique ImplantsPMA supplement
P040050-S012 · Decided Jul 15, 2019 · 89 days after receipt · Normal 180 Day Track
Device type: AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE (LNM) · GI, Urology & Nephrology
- MACROPLASTIQUE IMPLANTS, MPQ-2.5PMA supplement
P040050-S010 · Decided Dec 28, 2012 · 86 days after receipt · Normal 180 Day Track
Device type: AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE (LNM) · GI, Urology & Nephrology
3 more FDA decisions with a free account
Older decisions: P040050-S001, P040050
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Macroplastique", any status and sponsor, newest update first.
- Randomized Controlled Trial of Shunt vs ETV/CPC for PIH in Ugandan InfantsPivotal-lookingCompleted
Boston Children's HospitalAcademic, hospital or other
NCT01936272 · 100 participants · Start May 27, 2013 · Primary completion Jun 2026
Device: Chhabra Shunt Placement · For: Hydrocephalus
Sites: Mbale, Uganda
- HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in InfantsPivotal-lookingActive, not recruiting
University of UtahAcademic, hospital or other
NCT04177914 · 165 participants · Start Jul 21, 2020 · Primary completion May 30, 2027
Device: Ventriculoperitoneal Shunt · For: Hydrocephalus
Sites: Birmingham, Alabama; Phoenix, Arizona; Los Angeles, California · 21 sites in all
Indiana UniversityAcademic, hospital or other
NCT05898074 · 30 participants (planned) · Start Oct 9, 2023 · Primary completion Dec 15, 2026
Device: Non-Absorbable Packing (Silastic Splint); PuraGel (RADA16) Hydrogel · For: Skull Base Neoplasms; Cerebrospinal Fluid Leakage; Nasal; Hypertrophy, Mucous Membrane (Septum)
Sites: Indianapolis, Indiana
15 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Macroplastique", and for the whole product code for context.
This brand
34 reports: 24 malfunction, 8 injury, 0 death
Whole product code LNM
544 reports: 170 malfunction, 369 injury, 2 death
Newest reports for this brand
- MACROPLASTIQUE IMPLANTSMalfunction
3017448360-2023-00013 · Received Jun 30, 2023 · Event dated May 16, 2023
Device type: Agent, Bulking, Injectable For Gastro-Urology Use (LNM)
Device problem as coded: Material Erosion
Patient problem as coded: Failure of Implant
- MACROPLASTIQUE IMPLANTSInjury
3017448360-2022-00011 · Received Oct 24, 2022 · Event dated Sep 23, 2022
Device type: Agent, Bulking, Injectable For Gastro-Urology Use (LNM)
Device problem as coded: Material Erosion
Patient problem as coded: Failure of Implant
- MACROPLASTIQUE IMPLANTSMalfunction
3002647932-2021-00004 · Received Aug 4, 2021
Device type: Agent, Bulking, Injectable For Gastro-Urology Use (LNM)
Device problem as coded: Contamination /Decontamination Problem
Patient problem as coded: Calcium Deposits/Calcification
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Macroplastique"[tiab]. The summary above synthesizes these.
- Clinical presentation and treatment of Macroplastique® urethral exposures: a retrospective case series.
Ramirez-Caban L, Malekzadeh M, Ossin DA, et al. · Int Urogynecol J · 2022
- Macroplastique Is a Safe and Effective Long-term Surgical Treatment for Stress Urinary Incontinence: Prospective Study with 10-Year Follow-up.
Serati M, Scancarello C, Mesiano G, et al. · Eur Urol Focus · 2025
- Does the Polydimethylsiloxane Urethral Injection (Macroplastique®) Improve Sexual Function in Women, in Fertile Age, Affected by Stress Urinary Incontinence?
Serati M, Braga A, Scancarello C, et al. · Medicina (Kaunas) · 2023
- Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial.
Maher CF, O'Reilly BA, Dwyer PL, et al. · BJOG · 2005Clinical Trial, Comparative Study
- Long-term Outcomes With Macroplastique in Women With Stress Urinary Incontinence Secondary to Intrinsic Sphincter Deficiency.
Kusin SB, Carroll TF, Alhalabi F, et al. · Urology · 2024
- Macroplastique implantation system for the treatment of female stress urinary incontinence.
Tamanini JT, D'Ancona CA, Tadini V, et al. · J Urol · 2003Clinical Trial
- Outcomes of Macroplastique injections for stress urinary incontinence after suburethral sling removal.
Rodríguez D, Carroll T, Alhalabi F, et al. · Neurourol Urodyn · 2020
- The role of macroplastique implantation in the management of occult urinary stress incontinence.
Montera R, Scaletta G, Plotti F, et al. · Eur J Obstet Gynecol Reprod Biol · 2018
- Transurethral implantation of macroplastique for the treatment of female stress urinary incontinence secondary to urethral sphincter deficiency.
Radley SC, Chapple CR, Mitsogiannis IC, et al. · Eur Urol · 2001Clinical Trial
- Bilateral calcified Macroplastique® after 12 years.
Barone B, De Luca L, Napolitano L, et al. · Asian J Urol · 2022
- Macroplastique for women with stress urinary incontinence secondary to intrinsic sphincter deficiency.
Carroll TF, Christie A, Foreman M, et al. · Int Braz J Urol · 2019Evaluation Study
- Bladder neck and urethral erosions after Macroplastique injections.
Rodríguez D, Jaffer A, Hilmy M, et al. · Low Urin Tract Symptoms · 2021Multicenter Study
Other devices of this type
Also filed under product code LNM.
- Deflux Injectable GelPalette Life Sciences · PMA 2016
- Solesta (Injectable Gel)Palette Life Sciences · PMA 2021
- Durasphere Injectable Bulking AgentCarbon Medical Technologies, Inc. · PMA 2026
- Coaptite Injectable ImplantMerz North America, Inc. · PMA 2024
- Contigen Bard Collagen ImplantAllergan, Inc. · PMA 2009
- Bard Tegress Urethral ImplantC.R. Bard, Inc. · PMA 2006
- Enteryx Procedure KitBoston Scientific Corp · PMA 2005
- Durasphere ExpCarbon Medical Technologies, Inc. · PMA 2004
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.